Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day
Study Details
Study Description
Brief Summary
To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared supplementing the luteal phase with three small doses (500 IU) of HCG and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Small doses of HCG Supplementing the luteal phase with three small doses (500 IU) of HCG after trigger with GnRH agonist in antagonist IVF/ICSI cycles in high responders |
Procedure: IVF/ICSI
Drug: Human Chorionic Gonadotropin
Given in different doses and timing to support the luteal phase
|
Active Comparator: Booster HCG dose Booster HCG dose GnRH agonist only to trigger final maturation followed by a booster dose of 1500 IU of HCG on the day of ovum pickup |
Procedure: IVF/ICSI
Drug: Human Chorionic Gonadotropin
Given in different doses and timing to support the luteal phase
|
Outcome Measures
Primary Outcome Measures
- Clinical pregnancy rate [1 year]
The number of cycles with a positive pregnancy test and evidence of a gestational sac with fetal pulsations after 5weeks from pregnancy test
Secondary Outcome Measures
- OHSS rate [1 year]
The number of cycles with evidence of OHSS
Other Outcome Measures
- Chemical pregnancy rate [1 year]
The number of cycles with a positive pregnancy test after 14 days from embryo transfer
- Early miscarriage rate [1 year]
Pregnancies that end up with miscarriage before 12 weeks gestation
- Ongoing pregnancy rate [1 year]
Pregnancies ongoing beyond 12 weeks gestation
- Live birth rate [1 year]
Pregnancies resulting in a live birth
Eligibility Criteria
Criteria
Inclusion Criteria:
-
High responder females undergoing antagonist protocol IVF/ICSI cycle
-
More than 14 MII oocytes
-
Estradiol more than 3500 pg/ml on day of trigger
Exclusion Criteria:
-
Any other protocol
-
Normal or poor responders
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini) | Cairo | Egypt | ||
2 | Adam International hospital | Giza | Egypt | ||
3 | Nile IVF center | Giza | Egypt |
Sponsors and Collaborators
- Cairo University
- Nile Ivf Center, Cairo, Egypt
- Adam International Hospital
Investigators
- Study Director: Sarwat Ahwany, MD, Cairo University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 22015